ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $628,366 | -19.5% | 17,626 | +4.2% | 0.00% | -100.0% |
| Q2 2023 | $780,611 | +15.0% | 16,922 | -0.1% | 0.00% | – |
| Q1 2023 | $678,974 | -19.8% | 16,932 | -7.3% | 0.00% | -100.0% |
| Q4 2022 | $846,449 | +30.0% | 18,270 | +16.2% | 0.00% | 0.0% |
| Q3 2022 | $651,000 | -33.7% | 15,724 | -4.5% | 0.00% | 0.0% |
| Q2 2022 | $982,000 | -4.8% | 16,459 | +15.9% | 0.00% | 0.0% |
| Q1 2022 | $1,031,000 | -14.9% | 14,195 | -1.4% | 0.00% | 0.0% |
| Q4 2021 | $1,211,000 | -32.0% | 14,403 | -27.0% | 0.00% | 0.0% |
| Q3 2021 | $1,780,000 | -16.0% | 19,735 | -11.2% | 0.00% | 0.0% |
| Q2 2021 | $2,119,000 | -76.7% | 22,222 | -72.2% | 0.00% | -83.3% |
| Q1 2021 | $9,088,000 | +131.5% | 79,818 | +181.4% | 0.01% | +100.0% |
| Q4 2020 | $3,926,000 | +127.6% | 28,360 | +35.1% | 0.00% | +200.0% |
| Q3 2020 | $1,725,000 | +0.4% | 20,990 | -4.4% | 0.00% | -50.0% |
| Q2 2020 | $1,718,000 | +141.3% | 21,961 | +37.1% | 0.00% | +100.0% |
| Q1 2020 | $712,000 | +5.6% | 16,024 | +1.6% | 0.00% | 0.0% |
| Q4 2019 | $674,000 | -8.8% | 15,778 | -8.7% | 0.00% | 0.0% |
| Q3 2019 | $739,000 | -25.6% | 17,279 | +10.5% | 0.00% | 0.0% |
| Q2 2019 | $993,000 | -4.3% | 15,635 | +4.4% | 0.00% | 0.0% |
| Q1 2019 | $1,038,000 | +77.7% | 14,978 | +11.4% | 0.00% | 0.0% |
| Q4 2018 | $584,000 | -54.1% | 13,440 | -19.3% | 0.00% | 0.0% |
| Q3 2018 | $1,271,000 | +15.7% | 16,654 | +16.5% | 0.00% | 0.0% |
| Q2 2018 | $1,099,000 | +64.8% | 14,297 | +9.3% | 0.00% | 0.0% |
| Q1 2018 | $667,000 | +9.5% | 13,081 | -0.5% | 0.00% | 0.0% |
| Q4 2017 | $609,000 | -84.2% | 13,142 | -81.8% | 0.00% | -75.0% |
| Q3 2017 | $3,855,000 | -15.4% | 72,389 | -1.4% | 0.00% | -20.0% |
| Q2 2017 | $4,559,000 | -7.5% | 73,412 | +1.0% | 0.01% | -16.7% |
| Q1 2017 | $4,927,000 | -3.6% | 72,690 | -0.0% | 0.01% | 0.0% |
| Q4 2016 | $5,112,000 | +1.3% | 72,705 | +2.2% | 0.01% | -14.3% |
| Q3 2016 | $5,048,000 | +54.3% | 71,164 | +6.4% | 0.01% | +40.0% |
| Q2 2016 | $3,272,000 | -24.6% | 66,892 | -2.4% | 0.01% | -16.7% |
| Q1 2016 | $4,341,000 | -43.7% | 68,566 | -0.3% | 0.01% | -45.5% |
| Q4 2015 | $7,711,000 | +16.7% | 68,738 | +0.2% | 0.01% | +10.0% |
| Q3 2015 | $6,606,000 | +1092.4% | 68,583 | +1167.0% | 0.01% | +900.0% |
| Q2 2015 | $554,000 | -57.1% | 5,413 | -79.5% | 0.00% | -50.0% |
| Q1 2014 | $1,291,000 | – | 26,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 38,100 | $2,928,000 | 1.67% |
| Opaleye Management Inc. | 80,000 | $6,149,000 | 1.59% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 410,000 | $31,517,000 | 1.06% |
| Opus Point Partners Management, LLC | 6,311 | $485,000 | 1.05% |
| SECTOR GAMMA AS | 68,015 | $5,228,000 | 0.87% |
| Capital Impact Advisors, LLC | 27,074 | $2,061,000 | 0.76% |
| FORTALEZA ASSET MANAGEMENT INC/ | 1,130 | $87,000 | 0.71% |
| CAPITAL INTERNATIONAL LTD /CA/ | 46,957 | $3,610,000 | 0.63% |
| Virtus ETF Advisers LLC | 8,794 | $676,000 | 0.60% |
| Rock Springs Capital Management LP | 200,000 | $15,374,000 | 0.59% |